Table 1. Clinicopathological characteristics of patient samples and expression of URG4 in bladder cancer.
| Characteristics | Number of cases (%) |
|---|---|
| Age (years) | |
| <64 | 81(47.1) |
| ≥64 | 91(52.9) |
| Gender | |
| Male | 157(91.2) |
| Female | 15(8.8) |
| Degree of differentiation | |
| I | 32(18.6) |
| II | 53(30.8) |
| III | 87(50.6) |
| T classification | |
| T1 | 90(52.3) |
| T2 | 82(47.7) |
| N classification | |
| N0 | 150(87.2) |
| N1 | 22(12.8) |
| Number | |
| <3 | 108(62.8) |
| ≥3 | 64(37.2) |
| Vital status (at follow-up) | |
| alive | 67(39.0) |
| Dead | 105(61.0) |
| Expression of URG4 | |
| Low expression | 66(38.4) |
| High expression | 106(61.6) |
| Size | |
| <3 | 72(41.9) |
| ≥3 | 100(58.4) |
| Recurrence | |
| Yes | 82(47.7) |
| No | 90(52.3) |